Centro Medico Austral

CABA C1019ABS

1 studies enrolling now · 2 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, Urothelial Carcinoma

Studies at this site

• A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2 — Recruiting now
• A Study Of Lorlatinib Versus Crizotinib In First Line Treatment Of Patients With ALK-Positive NSCLC — Running, not enrolling